White Paper: Current State of Personal Protective Equipment Procurement by Make PPE in America Act Covered Agencies
Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFHEALTH AND HUMAN SERVICES, DEPARTMENT OFWashington, DC, 20201, US

Original Source

https://sam.gov/opp/5504fb8d0be4479f934cb2cadab1cd8a/view
Timeline
    Description

    Special Notice: HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking procurement of personal protective equipment (PPE) items in compliance with the Make PPE in America Act. This white paper provides insight into the PPE requirements, specifications, and anticipated demand of the covered agencies, including the U.S. Department of Homeland Security, U.S. Department of Health and Human Services, and the U.S. Department of Veterans Affairs. The Federal Government plans to gather feedback from industry through "industry convening" events to strengthen the domestic PPE supply chain and encourage innovation.

    Point(s) of Contact
    Marnita Harris
    acquisition_policy@hhs.gov
    Files
    Title
    Posted
    PPE White Paper - Final Mar 2024.pdf
    Similar Opportunities
    White Paper: Current State of Personal Protective Equipment Procurement by Make PPE in America Act Covered Agencies
    Active
    Homeland Security, Department Of
    Special Notice: Homeland Security, Department of is seeking procurement of personal protective equipment (PPE) items in compliance with the Make PPE in America Act. This white paper provides insight into the PPE requirements, specifications, and anticipated demand of the covered agencies (DHS, HHS, and VA). The purpose is to strengthen the domestic supply chain for PPE and encourage innovation. Industry feedback will be gathered through "industry convening" events after publication of the paper.
    White Paper: Current State of Personal Protective Equipment Procurement by Make PPE in America Act Covered Agencies
    Active
    Veterans Affairs, Department Of
    Special Notice: VETERANS AFFAIRS, DEPARTMENT OF is seeking procurement of personal protective equipment (PPE) items in compliance with the Make PPE in America Act. This white paper provides insight into the PPE requirements, specifications, and anticipated demand of the covered agencies (DHS, HHS, and VA). The purpose is to strengthen the domestic PPE supply chain and encourage innovation. Industry feedback will be gathered through "industry convening" events hosted by the Federal Government.
    Special Notice to Industry on Developments per the Make PPE in America Act
    Active
    Homeland Security, Department Of
    Special Notice: Homeland Security, Department of Homeland Security, Department of is posting a Special Notice on behalf of the interagency working group for implementation of the Make PPE in America Act. This notice is in collaboration with the U.S. Department of Health and Human Services (HHS), Department of Veterans Affairs (VA), and Office of Management and Budget, Made in America Office. The purpose of this notice is to inform industry about developments related to the Make PPE in America Act. The interagency working group plans to release a more detailed informational white paper in the first quarter of calendar year 2024.
    Industry Day: Make Personal Protective Equipment (PPE) in America Act
    Active
    Health And Human Services, Department Of
    Special Notice HEALTH AND HUMAN SERVICES, DEPARTMENT OF Industry Day: Make Personal Protective Equipment (PPE) in America Act The Department of Health and Human Services (HHS) is hosting an industry convening event to discuss the recently published White Paper on Personal Protective Equipment (PPE) as identified in the Make PPE in America Act. The purpose of this event is to obtain feedback from industry members regarding the information provided in the White Paper. The event will feature speakers from the Executive Office of the President and the agencies involved. The goal is to shape the Federal government's approach to buying PPE and support the domestic PPE manufacturing industry. The event is closed to the press and will not discuss specific procurement matters. The industry convening event will take place on Wednesday, May 1, 2024, from 2:00-2:45 PM EST in Washington, District of Columbia, United States. Interested participants are required to register by April 29, 2024, using the provided registration link. Questions related to the session should be sent to miacouncil.support@gsa.gov with the subject titled "PPE Industry Convening Event May 1, 2024" and the company name. Any questions following the event should be submitted by May 3, 2024, and a coordinated response will be posted on SAM.gov by May 24, 2024.
    Albuquerque Area Indian Health Service Personal Protective Equipment (PPE)
    Active
    Health And Human Services, Department Of
    Sources Sought HEALTH AND HUMAN SERVICES, DEPARTMENT OF ALBUQUERQUE AREA INDIAN HEALTH SVC The Albuquerque Area Indian Health Service is conducting a market survey to determine the availability of personal protective equipment (PPE) including surgical masks, respirator masks, powered air purifying respirators, face shields, protective eyewear, gloves, surgical and isolation gowns, head and foot coverings, and other gear or clothing used to protect against disease transmission. This notice is for informational and planning purposes only and is intended to gather information on potential qualified sources and their size classification/socioeconomic status. Interested vendors must sign a certificate confirming that all PPE provided is made in America. Responses to this notice will assist the Government in making appropriate acquisition decisions. Interested parties must be registered and certified in the System for Award Management (SAM) and submit a Statement of Capabilities (SOC) demonstrating their ability to manage the services.
    Nitrile and Vinyl Glove Testing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response, is seeking proposals for the testing of nitrile and vinyl gloves. This procurement aims to secure commercial testing services that adhere to the specifications outlined in the attached solicitation documents. The testing services are crucial for ensuring the quality and safety of medical gloves, which play a vital role in healthcare settings, particularly in infection control and patient safety. Interested vendors can reach out to Lawrence McCoy at Lawrence.Mccoy@hhs.gov or call 770-488-2087 for further details regarding the submission process and requirements.
    Nitrile and Vinyl Glove Testing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking proposals for laboratory testing services of disposable nitrile and vinyl examination gloves through a combined synopsis/solicitation (RFP 75A50324Q00016). The objective of this procurement is to validate these gloves to ensure compliance with applicable ASTM and ISO standards, which is critical for safeguarding healthcare workers and patients from infection risks. This testing initiative is part of a broader effort to maintain resilience in U.S. healthcare during emergencies by ensuring the availability of effective personal protective equipment. Proposals are due by September 20, 2024, for a Firm Fixed Price contract lasting from September 28, 2024, to April 27, 2025. Interested parties can contact Lawrence McCoy at Lawrence.Mccoy@hhs.gov for further information.
    RRPV Solicitation Summary: On-Demand Manufacturing
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (ASPR) through the Biomedical Advanced Research and Development Authority (BARDA), is seeking proposals for the "On-Demand Manufacturing" initiative under the Rapid Response Partnership Vehicle (RRPV) Consortium. The objective of this solicitation is to advance manufacturing technologies that enhance access and enable the rapid, cost-effective, and flexible production of vaccines and other biologics through decentralized manufacturing strategies. This initiative is crucial for improving the responsiveness of the healthcare system in times of need, particularly in the context of public health emergencies. Interested parties can find more information and access the full Request for Project Proposals (RPP) at the RRPV website, and inquiries can be directed to Rebecca Harmon at rebecca.harmon@ati.org.
    Pegfilgrastim with VMI
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking proposals for the procurement of Pegfilgrastim 6MG/.06ML (inj, soln, syr, or autoinjector) along with vendor-managed inventory (VMI) services to support national preparedness against public health emergencies. The contract will span five years, including a one-year base period and four optional ordering periods, with an initial quantity of 18,300 units projected to increase based on public health needs. This procurement is critical for maintaining robust health security capabilities and ensuring efficient supply chain management for essential pharmaceuticals. Interested contractors should direct inquiries to LaMonica Norwood at OSContracting@hhs.gov, with proposals due by the specified deadlines outlined in the RFP documentation.
    Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking proposals for the "Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability" through a Special Notice. The objective of this procurement is to establish a long-term partnership focused on developing a flexible and rapid response capability for vaccine development against pandemic influenza and other priority pathogens, initially emphasizing influenza mRNA vaccine development. This initiative is critical for enhancing the nation's preparedness and response to emerging infectious diseases, ensuring readiness to pivot quickly in the face of public health threats. Interested parties can access the full Request for Project Proposals and additional consortium information at www.rrpv.org, and inquiries can be directed to Rebecca Harmon at rebecca.harmon@ati.org.